protein that had been introduced into the organoid units prior to implantation. These marker studies strongly suggest that the neointestine was derived primarily from the neonatalderived intestine, as opposed to ingrowth of adjacent recipient intestine.
Like many excellent provocative studies, this report tends to raise many more questions. First, it is fundamental to understand the mechanism for the beneficial effect of the TESI. At the time of enterectomy and TESI-intestinal anastomosis, the TESI was noted to be approximately 4 cm in longitudinal diameter. Assuming the rats had an average baseline intestinal length of 72 cm prior to a greater than 80% intestinal resection, the added length of the TESI was arguably modest at best (approximately 10% of original intestinal length). It is not entirely convincing that the added mucosal surface area contributed by the relatively small length of TESI would have accounted for such a significant impact on postoperative weight gain. The fact that intestinal transit was significantly slower in the TESI animals would offer the possibility that the improved absorption and weight gain occurred because of the simple effect of the TESI on motility, rather than because of the added absorptive mucosal surface area. Along these lines, a common principle to slow transit and improve absorption is the feature of several simpler remedial procedures such as creation of reversed intestinal segments, intestinal valves, or colon interpositions.
Another question to consider is the clinical feasibility and advantages of TESI when compared with traditional surgical management. To harvest an ample volume of organoid units to seed polymers for 10 rats required the entire intestine from 40 neonatal rat pups. Thus, the overall yield from a relatively large amount of neonatal intestine to generate a comparatively short added length of TESI seems low. The considerations of the source and number of human neonatal intestines required to generate a significant contribution of intestinal length by TESI to an adult patient with SBS would therefore seem daunting.
Another major issue is the donor source of intestinal tissue for the organoid units and the possibility of transplant rejection. These patients would undoubtedly require longterm postoperative immunosuppression. The advantages of TESI, the need for human fetal or neonatal donor tissue, the requirement for at least 2 surgical procedures, and modest impact on intestinal length would have to be weighed against a single, traditional intestinal transplantation procedure in which the added intestinal length would be essentially curative. The morbidity associated with rejection and immunosuppression would be common to both approaches.
To address concerns regarding the source and quantity of donor intestine as well as the need for immunosuppression, the fundamental information derived from studies like this may lead to the ability to harvest organoid units for later implantation from the same patient. Perhaps some viable organoid units could be derived from the resected intestine at the time of enterectomy. Even more compelling would be the ability to harvest a useful population of organoid units from mucosal biopsies of the patient with SBS. These cells might be able to be expanded ex vivo and then reimplanted into the same individual at a later time.
It is apparent that there is much work to be done in this area. The principle of engineering tissue to replace the highly complex immune, absorptive, digestive, neural, mechanical, and hormonal features of a normal small intestine is both challenging and exciting. The Vacanti laboratory is to be commended for taking the lead in this innovative endeavor.
